Azithromycin Combination Therapy for the Treatment of Uncomplicated Falciparum Malaria in Bangladesh

Uncomplicated Falciparum Malaria Clinical Trial

Official title:
Azithromycin Combination Therapy for the Treatment of Uncomplicated Falciparum Malaria in Bangladesh: An Open Label Randomized Controlled Trial

Status Completed

Clinical Trial Summary

The purpose of this study is to investigate the efficacy of azithromycin combination therapy with artesunate for the treatment of uncomplicated falciparum malaria in Bangladesh.

Clinical Trial Description

In view of spreading antimalarial drug resistance there is an urgent need for new combination treatments for a disease that kills more than one million people every year. Azithromycin is a macrolide antibiotic that is particularly attractive due to its safety in children and experience with use in pregnancy. Recent trials suggest that azithromycin has a strong potential as an antimalarial. The purpose of this study is to investigate the efficacy of azithromycin combination therapy for the treatment of uncomplicated falciparum malaria in Bangladesh. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00356005
Study type	Interventional
Source	Medical University of Vienna
Contact
Status	Completed
Phase	Phase 2
Start date	August 2006

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT00936767` - Artemisone for the Treatment of Uncomplicated Falciparum Malaria in Western Cambodia	Phase 2/Phase 3
Withdrawn	`NCT02461186` - Arterolane-PQP Versus DHA-PQP in Uncomplicated Falciparum Malaria in Eastern Myanmar	Phase 2/Phase 3
Active, not recruiting	`NCT04009343` - Pharmacokinetics and Pharmacodynamics of the Gametocytocidal and Post-treatment Chemoprotective Effects of Antimalarials	Phase 2/Phase 3
Completed	`NCT00682578` - A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan	Phase 3
Completed	`NCT00959517` - Trial of Artesunate Combination Therapy in Pakistan	Phase 2
Completed	`NCT03431714` - Efficacy and Safety of ASAQ and PD for the Treatment of Uncomplicated Falciparum Malaria in Mainland Tanzania	Phase 4
Recruiting	`NCT00902811` - Effectiveness of Artemisinin Combination Regimens in Falciparum Malaria	Phase 4
Completed	`NCT01407887` - Efficacy and Safety of Artesunate-amodiaquine-methylene for Malaria Treatment in Children	Phase 2